Investigating the effectiveness, safety and tolerability of quetiapine in the treatment of anorexia nervosa in young people: A pilot study

Journal of Psychiatric Research

Volumn 44, Issue 15, 2010, Pages 1027-1034

  Court, Andrew ^a   Mulder, Claudia ^a   Kerr, Melissa ^a   Yuen, Hok Pan ^a   Boasman, Melissa ^a   Goldstone, Sherilyn ^a   Fleming, Judith ^b   Weigall, Susan ^b   Derham, Harry ^c   Huang, Chia ^c   McGorry, Patrick ^a   Berger, Gregor ^d  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c The Melbourne Clinic Eating Disorders Program   (Australia)

^d Clienia Schlössli Clinic Schlösslistrasse 8   (Switzerland)

Author keywords

Anorexia nervosa; Atypical antipsychotics; Eating disorder; Pharmacotherapy; Quetiapine

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CITALOPRAM; DIAZEPAM; ESCITALOPRAM; FLUOXETINE; LORAZEPAM; NITRAZEPAM; PLACEBO; QUETIAPINE; SERTRALINE; TEMAZEPAM; ZOLPIDEM; ZOPICLONE;

ADULT; ANOREXIA NERVOSA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE BEHAVIORAL STRESS MANAGEMENT; CONCENTRATION LOSS; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EVENING DOSAGE; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR DEPRESSION; MALE; MORNING DOSAGE; OPEN STUDY; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEDATION; SIDE EFFECT; TREATMENT AS USUAL; TREATMENT DURATION;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANOREXIA NERVOSA; ANTIPSYCHOTIC AGENTS; CLINICAL PROTOCOLS; DIBENZOTHIAZEPINES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; QUESTIONNAIRES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77958520435     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2010.03.011     Document Type: Article

References (29)

1. Attia E., Schroeder L. Pharmacologic treatment of anorexia nervosa: where do we go from here?. International Journal of Eating Disorders 2005, 37:S60-S63.
2. Barbarich N.C., McConaha C.W., Gaskill J., La Via M., Frank G.K., Achenbach S., Plotnicov K.H., Kaye W.H. An open trial of olanzapine in anorexia nervosa. Journal of Clinical Psychiatry 2004, 65:1480-1482.
3. Bissada H., Tasca G.A., Barber A.M., Bradwejn J. Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial. American Journal of Psychiatry 2008, 165:1281-1288.
4. Bosanac P., Kurlender S., Norman T., Hallam K., Wesnes K., Manktelow T., Burrows G. An open-label study of quetiapine in anorexia nervosa. Human Psychopharmacology 2007, 22:223-230.
5. Brambilla F., Garcia C.S., Fassino S., Daga G.A., Favaro A., Santonastaso P., Ramaciotti C., Bondi E., Mellado C., Boriello T., Monteleone P. Olanzapine therapy in anorexia nervosa: psychobiological effects. International Clinical Psychopharmacology 2007, 22:197-204.
6. Brecher M., Leong R.W., Stening G., Osterling-Koskinen L., Jones A.M. Quetiapine and long-term weight change: a comprehensive data review of patients with schizophrenia. Journal of Clinical Psychiatry 2007, 68:597-603.
7. Bruch H. Eating disorders: obesity, anorexia nervosa, and the person within 1973, Basic Books, Houston.
8. Court A., Mulder C., Hetrick S.E., Purcell R., McGorry P.D. What is the scientific evidence for the use of antipsychotic medication in anorexia nervosa?. Eating Disorders 2008, 16:217-223.
9. Cummins R.A. Personal Wellbeing Index-Adult 2006, Australian Centre for Quality of Life, Deakin University, Melbourne. 4th edition.
10. Fairburn C.G. Evidence-based treatment of anorexia nervosa. International Journal of Eating Disorders 2005, 37:S26-S30.
11. Garner D.M., Olmstead M.A., Polivy J. Development and validation of a multidimensional eating disorder inventory for anorexia and bulimia. International Journal of Eating Disorders 1983, 2:15-34.
12. Grant J.E., Kim S.W., Eckert E.D. Body dysmorphic disorder in patients with anorexia nervosa: prevalence, clinical features, and delusionality of body image. International Journal of Eating Disorders 2002, 32:291-300.
13. Guarda A.S. Treatment of anorexia nervosa: insights and obstacles. Physiology and Behaviour 2008, 94:113-120.
14. Jones E., Watson J.P. Delusion, the overvalued idea and religious beliefs: a comparative analysis of their characteristics. British Journal of Psychiatry 1997, 170:381-386.
15. Keel P.K., Haedt A. Evidence-based psychosocial treatments for eating problems and eating disorders. Journal of Clinical Child and Adolescent Psychology 2008, 37:39-61.
16. Lingjaerde O., Ahlfors U.G., Bech P., Dencker S.J., Elgen K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatrica Scandinavica 1987, 334:S1-S100.
17. Lewinsohn P.M., Striegel-Moore R.H., Seeley J.R. Epidemiology and natural course of eating disorders in young women from adolescence to young adulthood. Journal of the American Academy of Child and Adolescent Psychiatry 2000, 39:1284-1292.
18. Mehler-Wex C., Romanos M., Kirchheiner J., Schulze U.M. Atypical antipsychotics in severe anorexia nervosa in children and adolescents-review and case reports. European Eating Disorders Review 2008, 16:100-108.
19. Mondraty N., Birmingham C.L., Touyz S., Sundakov V., Chapman L., Beumont P. Randomized controlled trial of olanzapine in the treatment of cognitions in anorexia nervosa. Australasian Psychiatry 2005, 13:72-75.
20. Powers P.S., Santana C.A., Bannon Y.S. Olanzapine in the treatment of anorexia nervosa: an open label trial. International Journal of Eating Disorders 2002, 32:146-154.
21. Powers P.S., Bannon Y., Eubanks R., McCormick T. Quetiapine in anorexia nervosa patients: an open label outpatient pilot study. International Journal of Eating Disorders 2007, 40:21-26.
22. Roberts R.E., Vernon S.W. The Center for Epidemiologic Studies Depression Scale: its use in a community sample. American Journal of Psychiatry 1983, 140:41-46.
23. Rowe D.L. Off-label prescription of quetiapine in psychiatric disorders. Expert Reviews in Neurotherapeutics 2007, 7:841-852.
24. Steinglass J.E., Eisen J.L., Attia E., Mayer L., Walsh B.T. Is anorexia nervosa a delusional disorder? An assessment of eating beliefs in anorexia nervosa. Journal of Psychiatric Practice 2007, 13:65-71.
25. Taylor P.J., Garety P., Buchanan A., Reed A., Wessely S.C., Ray K., Dunn G., Grubin D. The Maudsley Assessment of Delusions Schedule 1994, University of Chicago, Chicago, IL.
26. Vandereycken W., Pierloot R. Pimozide combined with behavior therapy in the short-term treatment of anorexia nervosa. A double-blind placebo-controlled cross-over study. Acta Psychiatrica Scandinavica 1982, 66:445-450.
27. Vandereycken W. Neuroleptics in the short-term treatment of anorexia nervosa. A double-blind placebo-controlled study with sulpiride. British Journal of Psychiatry 1984, 144:288-292.
28. Walsh B.T., Kaplan A.S., Attia E., Olmsted M., Parides M., Carter J.C., Pike K.M., Devlin M.J., Woodside B., Roberto C.A., Rockert W. Fluoxetine after weight restoration in anorexia nervosa. Journal of the American Medical Association 2006, 295:2605-2612.
29. Watson D., Weber K., Assenheimer J.S., Clark L.A., Strauss M.E., McCormick R.A. Testing a tripartite model: I. evaluating the convergent and discriminant validity of anxiety and depression symptom scales. Journal of Abnormal Psychology 1995, 104:3-14.